Could a common heart pill help prevent aortic ruptures?
NCT ID NCT07483177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether spironolactone, a medication that blocks aldosterone, can reduce stiffness in the aorta for people with a thoracic aortic aneurysm. About 50 adults with an enlarged aorta will receive either spironolactone or a placebo for a short time. The goal is to see if this drug can help control the disease and lower the risk of complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Ultrasound reveals hidden brain risks during aortic stent surgery
- Stent-Graft device under scrutiny for aortic aneurysm and dissection repair
- Digital twins could make aorta surgery safer and smarter
- Can we predict which aneurysms will turn dangerous?
- New stent aims to fix aortic arch without open surgery